Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Neumora Therapeutics (NMRA) SEC Filings & 10K Form

Neumora Therapeutics logo
$1.50 +0.06 (+3.82%)
As of 01:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Neumora Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/06/2025
3:31 PM		Neumora Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/30/2025
5:25 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM		Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:31 PM		Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
4:21 PM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
3:42 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
11:15 PM		Neumora Therapeutics (Filer)
Form EFFECT
03/12/2025
3:49 PM		Gosebruch Henry O (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:41 PM		Neumora Therapeutics (Filer)
Form POS AM
03/03/2025
3:44 PM		Neumora Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:32 AM		Neumora Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:06 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:12 AM		Neumora Therapeutics (Filer)
Form POSASR
02/20/2025
4:11 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:12 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:13 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:14 PM		Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:14 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:51 PM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:00 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:10 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:01 PM		BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:33 PM		ARCH Venture Fund XII, L.P. (Filed by)
Neumora Therapeutics (Subject)
Form SC 13D/A
Amazon’s big Bitcoin embarrassment (Ad)

Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.

Watch the Bitcoin Skimming strategy here
11/12/2024
6:17 AM		Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
5:25 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:01 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
3:26 PM		Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:10 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:30 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
3:10 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
4:22 PM		Neumora Therapeutics (Filer)
Form S-3ASR
09/19/2024
3:35 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:37 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:22 PM		Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:18 PM		Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
4:58 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
5:17 PM		Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
8:48 AM		Neumora Therapeutics (Subject)
Pinto Joshua (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NMRA) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
Turn your "dead money" into $306+ monthly (starting this month)
Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...
Investors Alley | Sponsored
My shocking meeting in Washington, D.C.
After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...
Brownstone Research | Sponsored
Big Changes Coming in August — Is Your IRA Ready?
Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...
Reagan Gold Group | Sponsored
#1 Pre-IPO Opportunity For 2025 [Take Action Now!]
James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...
Paradigm Press | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
The stealth altcoin the financial world is underestimating
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsored
Silver Demand Is Exploding—and Supply Can’t Keep Up
Elon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...
Priority Gold | Sponsored